Edit |   |
---|---|
Antigenic Specificity | SARS-CoV-2 RBD (Regdanvimab biosimilar) |
Clone | Regdanvimab (CT-P59 ) |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | Human IgG |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-SARS-CoV-2 RBD Recombinant Antibody (Regdanvimab (CT-P59 )). Regdanvimab is a monoclonal antibody under investigation for the treatment of coronavirus disease 2019 (COVID 19). |
Immunogen | n/a |
Other Names | Anti-RBD Recombinant Antibody, Research Grade Regdanvimab(CT-P59 ), Anti-SARS-CoV-2 RBD Recombinant Antibody(Regdanvimab(CT-P59 )), , Antibody Drug Analogues, Monoclonal Antibody, YR1644, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | n/a |
Catalog # | YR1644 |
Price | please inquire |
Order / More Info | SARS-CoV-2 RBD (Regdanvimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |